Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Guidelines on HRT to Be Completed in November
June 9, 2008
- Towa Pharm.: Sales, Profits Fall Short of Mid-Term Plan
June 9, 2008
- Sutent Drug of Choice for Progressive RCC
June 9, 2008
- GENERICS NEWS IN BRIEF
June 9, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 9, 2008
- Pharma Industry Must Be Trusted by the Public: Dr Takenaka
June 9, 2008
- Mr Shoda to Lead JPMA to Create Innovation-Friendly NHI Pricing System
June 9, 2008
- Otsuka: Pharma Sales Up 11.1% to \640.2 Bil.
June 2, 2008
- Individual Doctors Should Be Free to Choose Generics or Original Drugs: Dr Fujiwara of JMA
June 2, 2008
- Ono: Opalmon Pushes Up Sales by 3.0%
June 2, 2008
- Daiichi Sankyo to Acquire U3 Pharma of Germany
June 2, 2008
- Will Generics Take Off? (Final)
June 2, 2008
- Kyorin: Sales Up 5.2% Driven by Good Sales of Kipres
June 2, 2008
- Protosera Cooperates with 5 Firms to Search for Biomarkers
June 2, 2008
- SELF-MEDICATION NEWS IN BRIEF
June 2, 2008
- Kaken: Artz Drives 4.6% Increase in Sales
June 2, 2008
- MEDICAL DEVICE NEWS IN BRIEF
June 2, 2008
- JPMA Predicts \1.7 Tril. Shrinkage of Market under NHI Pricing System Proposed by It
June 2, 2008
- Mochida: Record-high Profits Driven by Epadel, Atelec
June 2, 2008
- JSMI Calls on Original Makers to Cooperate in Development of Switch OTC Drugs
June 2, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…